Skip to menu Skip to content Skip to footer

2025

Conference Publication

Development of novel 18F-PET imaging probes for mTOR signaling in Focal cortical Dysplasia type II

Almass, Adrian, Paterson, Brett, Humphries, James, Grieve, Melyssa, Stimson, Damion, Migotto, Mary-anne, Cowin, Gary and Reutens, David (2025). Development of novel 18F-PET imaging probes for mTOR signaling in Focal cortical Dysplasia type II. International Symposium on Radiopharmaceutical Sciences iSRS 2025, Gold Coast, QLD, Australia, 11-15 May 2025. Philadelphia, PA, United States: Elsevier. doi: 10.1016/j.nucmedbio.2025.109196

Development of novel 18F-PET imaging probes for mTOR signaling in Focal cortical Dysplasia type II

2023

Conference Publication

A HER2 targeted polylysine dendrimer nanoparticle radiotheranostic demonstrates excellent tumor accumulation, rapid clearance from circulation, and promising performance in PET-CT imaging

Johnstone, Cameron N., Heery, Graham P., Kelly, Brian D, Humphries, James, Akhter, Dewan T., Thurecht, Kristofer J., Yuen, Daniel, Giannis, Michael, Yong, Ken, Chadwick, Gareth, Barker, Helena, Cargill, Anne, Eglezos, Anthony, Castellarnau, Alex, Paull, Jeremy R. A. and Hufton, Richard (2023). A HER2 targeted polylysine dendrimer nanoparticle radiotheranostic demonstrates excellent tumor accumulation, rapid clearance from circulation, and promising performance in PET-CT imaging. AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, Boston, MA United States, 11-15 October 2023. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1535-7163.targ-23-a147

A HER2 targeted polylysine dendrimer nanoparticle radiotheranostic demonstrates excellent tumor accumulation, rapid clearance from circulation, and promising performance in PET-CT imaging